River Road Asset Management’s Novartis NVS Stock Holding History

River Road Asset Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-2,233	Closed	-$211K	–	169
2020 Q4	$211K	Buy	+2,233	New	+$195K	﹤0.01%	140
2019 Q4	–	Sell	-2,375	Closed	-$206K	–	164
2019 Q3	$206K	Sell	2,375 -62	-3%	-$5.57K	﹤0.01%	156
2019 Q2	$223K	Sell	2,437 -182	-7%	-$15.4K	﹤0.01%	161
2019 Q1	$226K	Buy	+2,619	New	+$210K	0.01%	156
2018 Q4	–	Sell	-3,002	Closed	-$232K	–	175
2018 Q3	$232K	Sell	3,002 -188	-6%	-$13.9K	﹤0.01%	157
2018 Q2	$216K	Hold	3,190	–	–	﹤0.01%	162
2018 Q1	$231K	Sell	3,190 -195	-6%	-$14.8K	﹤0.01%	162
2017 Q4	$255K	Buy	3,385 +281	+9%	+$21.2K	﹤0.01%	157
2017 Q3	$239K	Buy	+3,104	New	+$234K	﹤0.01%	154

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

River Road Asset Management's NVS Position: Q1 2021 in Review

River Road Asset Management sold out of Novartis (NVS) in Q1 2021, closing a stake of 2,233 shares — an estimated $211K sold.

River Road Asset Management first reported a position in NVS in Q3 2017 and held it in 9 quarters. The position peaked at $255K in Q4 2017. 1,135 funds tracked by Wall St. Rank hold NVS as of Q1 2021.

River Road Asset Management reported no remaining Novartis position as of Q1 2021 after selling out during the quarter.
River Road Asset Management sold 2,233 Novartis shares in Q1 2021, an estimated $211K.
River Road Asset Management first reported a position in Novartis in Q3 2017 and held it in 9 quarters.
River Road Asset Management's Novartis position peaked at $255K in Q4 2017.
1,135 funds tracked by Wall St. Rank held Novartis as of Q1 2021.

Based on River Road Asset Management's 13F filing for Q1 2021, filed 12 May 2021.